Clinical Approach to Orthopnea
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of Orthopnea
Orthopnea is a cardinal symptom of heart failure, present in approximately 50% of patients with left ventricular dysfunction. Among patients presenting with acute dyspnea to the emergency department, orthopnea has a positive likelihood ratio of 2.2 for heart failure when present and a negative likelihood ratio of 0.65 when absent. This symptom significantly impacts quality of life and sleep quality, with studies showing that patients with orthopnea have a 30% higher rate of sleep disturbance compared to those without. Understanding orthopnea is essential for early recognition of cardiac decompensation and guides both diagnostic workup and therapeutic interventions.
Definition
Orthopnea is dyspnea (shortness of breath) that occurs in the recumbent (lying flat) position and is relieved, either partially or completely, by sitting upright or standing. The term derives from the Greek words “ortho” (straight or upright) and “pnea” (breathing). It is quantified clinically by the number of pillows a patient requires to sleep comfortably or the degree of head elevation needed to prevent breathlessness.
Key Epidemiology
- Heart failure prevalence: Present in 50-70% of patients with symptomatic heart failure
- Sensitivity for heart failure: Approximately 50% (moderate sensitivity)
- Specificity for heart failure: Approximately 77% (moderately high specificity)
- Prognostic value: Presence of orthopnea is associated with more advanced heart failure (New York Heart Association Class III-IV)
Classification by Severity
| Severity Grade | Number of Pillows | Angle of Elevation | Clinical Implication |
|---|---|---|---|
| Mild (1-pillow) | 1-2 pillows | 15-30 degrees | Early cardiac decompensation; may respond well to outpatient management |
| Moderate (2-pillow) | 2-3 pillows | 30-45 degrees | Moderate congestion; requires optimization of therapy; close monitoring needed |
| Severe (3+ pillow) | 3 or more pillows or sleeping in chair | Greater than 45 degrees | Severe congestion; often requires hospitalization; risk of acute pulmonary edema |
Classification by Onset and Duration
| Category | Duration | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute | Hours to days | Acute heart failure exacerbation, acute myocardial infarction, flash pulmonary edema, acute valvular dysfunction | Medical emergency; requires urgent evaluation and treatment |
| Subacute | Days to weeks | Progressive heart failure decompensation, medication non-compliance, dietary indiscretion, new arrhythmia | Opportunity for intervention before acute decompensation |
| Chronic | Weeks to months | Chronic heart failure, chronic valvular disease, obesity hypoventilation syndrome, chronic obstructive pulmonary disease with cor pulmonale | Focus on long-term optimization and identifying reversible factors |
Classification by Character and Associated Features
Cardiac Orthopnea
Characteristics: Develops within minutes of lying flat; associated with peripheral edema, jugular venous distension, and third heart sound; typically worse at end of day due to fluid accumulation; improves with diuresis.
Key feature: Often accompanied by paroxysmal nocturnal dyspnea (sudden awakening with severe dyspnea 1-3 hours after falling asleep).
Pulmonary Orthopnea
Characteristics: May develop more gradually; associated with wheezing, cough, or sputum production; related to changes in lung mechanics in supine position; may be worse during respiratory infections.
Key feature: Patients with severe chronic obstructive pulmonary disease may experience orthopnea due to diaphragmatic disadvantage in recumbent position.
Classification by Pattern and Timing
| Pattern | Description | Suggests |
|---|---|---|
| Immediate onset | Dyspnea begins within seconds to minutes of lying flat | Severe heart failure with elevated left atrial pressure; massive pleural effusion; bilateral diaphragm paralysis |
| Delayed onset | Dyspnea develops after 15-30 minutes of recumbency | Moderate heart failure with gradual fluid redistribution; milder pulmonary congestion |
| Nocturnal predominance | Primarily occurs at night with paroxysmal awakening | Heart failure with paroxysmal nocturnal dyspnea; nocturnal asthma; sleep apnea |
| Position-specific | Worse lying on one side (trepopnea) | Unilateral pleural effusion; unilateral lung disease; cardiac mass or tumor |
| Postprandial worsening | Orthopnea worsens after meals | Heart failure with limited cardiac reserve; splanchnic blood redistribution |
Related Positional Dyspnea Variants
| Term | Definition | Key Associations |
|---|---|---|
| Paroxysmal Nocturnal Dyspnea | Sudden severe dyspnea waking patient from sleep, typically 1-3 hours after lying down; relieved by sitting upright for 15-30 minutes | Left ventricular failure; often more specific for heart failure than orthopnea alone |
| Trepopnea | Dyspnea occurring in one lateral decubitus position but not the other | Unilateral pleural effusion (worse lying on unaffected side); unilateral lung disease; cardiac tumors |
| Platypnea | Dyspnea occurring in the upright position, relieved by recumbency (opposite of orthopnea) | Intracardiac shunts (patent foramen ovale, atrial septal defect); hepatopulmonary syndrome; post-pneumonectomy |
| Bendopnea | Dyspnea occurring within 30 seconds of bending forward | Advanced heart failure with elevated filling pressures; poor cardiac reserve |
Key Concept: The “Cardiac Quartet”
Orthopnea is one of four classic symptoms of heart failure that together form a highly specific constellation:
- Orthopnea — Dyspnea when lying flat
- Paroxysmal nocturnal dyspnea — Sudden nocturnal awakening with severe dyspnea
- Peripheral edema — Bilateral lower extremity swelling
- Exertional dyspnea — Breathlessness with activity
When all four symptoms are present, the specificity for heart failure approaches 90%. However, remember that orthopnea is not exclusive to cardiac disease and requires systematic evaluation of all potential etiologies.
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of Orthopnea
Orthopnea results from complex physiological changes that occur when transitioning from upright to recumbent positions. In healthy individuals, these changes are well-compensated, but in patients with cardiac or pulmonary disease, the compensatory mechanisms fail, leading to dyspnea. Understanding these mechanisms is crucial for appropriate diagnosis and targeted therapy.
The Central Mechanism: Fluid Redistribution
Core Pathophysiology
When a patient lies flat, approximately 500-800 mL of blood redistributes from the lower extremities and splanchnic circulation to the central circulation within minutes. In patients with impaired left ventricular function, this increased venous return cannot be adequately handled, leading to elevated pulmonary venous pressure and pulmonary congestion.
Physiological Changes with Recumbency
| Parameter | Change When Supine | Effect in Healthy Individuals | Effect in Heart Failure |
|---|---|---|---|
| Venous Return | Increases by 25-30% | Well-compensated; stroke volume increases appropriately | Left ventricle cannot accommodate increased preload; backs up into pulmonary circulation |
| Central Blood Volume | Increases by 500-800 mL | Distributed throughout compliant pulmonary and systemic circulations | Pulmonary venous congestion; interstitial and alveolar edema |
| Pulmonary Capillary Wedge Pressure | Increases by 2-4 mmHg | Remains within normal range (less than 15 mmHg) | May exceed 25 mmHg, causing transudation into alveoli |
| Functional Residual Capacity | Decreases by approximately 500 mL | Minimal impact on oxygenation | Further reduction in already compromised lung volumes; airway closure |
| Diaphragm Position | Moves cephalad (upward) by 2-4 cm | Compensated by intercostal muscle recruitment | Mechanical disadvantage; reduced tidal volume; increased work of breathing |
Pathophysiological Pathways
Hemodynamic Pathway
Trigger: Increased venous return
Mechanism: Failing left ventricle cannot accommodate increased preload, leading to elevated left atrial and pulmonary venous pressures
Result: Pulmonary capillary pressure exceeds oncotic pressure (greater than 25 mmHg), causing fluid transudation into interstitium and alveoli
Mechanical Pathway
Trigger: Supine positioning
Mechanism: Cephalad displacement of abdominal contents pushes diaphragm upward; pulmonary congestion reduces lung compliance
Result: Decreased functional residual capacity, increased work of breathing, ventilation-perfusion mismatch
Neurohormonal Pathway
Trigger: Fluid redistribution and hypoxia
Mechanism: Activation of pulmonary J-receptors (juxtacapillary receptors) by interstitial edema; stimulation of peripheral and central chemoreceptors
Result: Sensation of dyspnea, rapid shallow breathing, sympathetic activation
Receptors and Neural Pathways in Orthopnea
| Receptor Type | Location | Stimulus | Clinical Relevance |
|---|---|---|---|
| Pulmonary J-Receptors | Alveolar-capillary interstitium | Interstitial edema, increased pulmonary capillary pressure | Primary mediators of dyspnea in heart failure; cause rapid shallow breathing pattern |
| Pulmonary Stretch Receptors | Airway smooth muscle | Lung inflation, airway stretch | Activated by decreased lung compliance; contribute to sensation of breathlessness |
| Peripheral Chemoreceptors | Carotid and aortic bodies | Hypoxemia, hypercapnia, acidosis | Stimulated by ventilation-perfusion mismatch causing hypoxemia |
| Central Chemoreceptors | Medulla oblongata | Elevated carbon dioxide, decreased pH in cerebrospinal fluid | May be stimulated in severe pulmonary congestion with respiratory acidosis |
| Chest Wall Mechanoreceptors | Intercostal muscles, diaphragm | Increased work of breathing, muscle tension | Sense increased respiratory effort; contribute to conscious perception of dyspnea |
How Different Conditions Cause Orthopnea
| Condition | Primary Mechanism | Treatment Implication |
|---|---|---|
| Heart Failure with Reduced Ejection Fraction | Impaired systolic function cannot handle increased preload; elevated filling pressures transmitted to pulmonary circulation | Diuretics to reduce preload; afterload reduction; inotropic support in severe cases |
| Heart Failure with Preserved Ejection Fraction | Impaired diastolic relaxation and increased stiffness prevent adequate filling; small increases in volume cause large pressure increases | Diuretics; heart rate control; treatment of underlying conditions (hypertension, diabetes) |
| Mitral Stenosis | Obstructed mitral valve prevents adequate left ventricular filling; increased venous return worsens left atrial pressure | Heart rate control to prolong diastole; diuretics; surgical or percutaneous intervention |
| Mitral Regurgitation | Increased venous return increases left ventricular volume, worsening regurgitant fraction and left atrial pressure | Afterload reduction; diuretics; surgical repair or replacement |
| Chronic Obstructive Pulmonary Disease | Supine position causes diaphragmatic disadvantage and increases work of breathing; may also have cor pulmonale component | Bronchodilators; positioning; treatment of right heart failure if present |
| Obesity Hypoventilation Syndrome | Abdominal mass pushes diaphragm cephalad; reduced chest wall compliance; increased oxygen consumption | Weight loss; nocturnal positive airway pressure; positioning |
| Bilateral Diaphragmatic Paralysis | Paralyzed diaphragm moves paradoxically with respiration; supine position eliminates gravity assistance to ventilation | Nocturnal ventilatory support; diaphragm pacing in select cases |
| Large Pleural Effusion | Fluid compresses lung tissue; supine position causes bilateral compression rather than gravity-dependent distribution | Thoracentesis; treatment of underlying cause |
| Ascites | Abdominal fluid pushes diaphragm upward; effect maximal in supine position | Paracentesis; diuretics; treatment of underlying cause |
Timeline of Physiological Changes After Lying Flat
Sequence of Events in Cardiac Orthopnea:
- 0-2 minutes: Blood redistribution from lower extremities to central circulation begins; venous return to right heart increases
- 2-5 minutes: Right ventricular output increases; pulmonary blood volume rises; left atrial pressure begins to elevate
- 5-15 minutes: Pulmonary capillary pressure exceeds threshold; interstitial edema develops; J-receptors activated
- 15-30 minutes: Alveolar flooding may begin if pressure remains elevated; severe dyspnea; patient sits upright for relief
- 1-3 hours (if sleeping): Gradual fluid mobilization from peripheral tissues; may trigger paroxysmal nocturnal dyspnea
Why Healthy Individuals Don’t Experience Orthopnea
| Compensatory Mechanism | How It Works | Why It Fails in Disease |
|---|---|---|
| Frank-Starling Mechanism | Increased preload leads to increased contractility and stroke volume | Failing ventricle operates on flat portion of curve; cannot increase output with increased preload |
| Lymphatic Drainage | Pulmonary lymphatics clear excess interstitial fluid | Lymphatic capacity overwhelmed when capillary filtration exceeds 20-fold normal |
| Venous Capacitance | Compliant venous system accommodates volume shifts | Reduced venous compliance in heart failure; fluid shifts cause larger pressure changes |
| Respiratory Muscle Adaptation | Intercostal muscles compensate for diaphragmatic displacement | Respiratory muscle fatigue in chronic disease; reduced reserve capacity |
Often Overlooked Mechanism: Nocturnal Fluid Redistribution
During the day, patients with heart failure accumulate fluid in dependent tissues (peripheral edema). At night, when supine, this peripheral edema is mobilized back into the central circulation over 1-3 hours, causing delayed pulmonary congestion. This explains why paroxysmal nocturnal dyspnea typically occurs several hours after lying down, rather than immediately like orthopnea. The phenomenon also explains why morning weight is often the most accurate measure of fluid status and why patients may have significant volume overload despite minimal daytime symptoms.
Consequences of Persistent Orthopnea
Immediate Consequences
- Sleep deprivation and fatigue
- Nocturnal hypoxemia
- Sympathetic nervous system activation
- Increased myocardial oxygen demand
- Reduced quality of life
Long-term Consequences
- Progressive cardiac remodeling
- Development of pulmonary hypertension
- Risk of acute pulmonary edema
- Respiratory muscle weakness
- Increased mortality risk
3. History Taking
A comprehensive approach to eliciting the Orthopnea history
Red Flags — Require Urgent Evaluation
- Acute onset orthopnea with chest pain — Acute coronary syndrome, aortic dissection
- Orthopnea with pink frothy sputum — Acute pulmonary edema
- Severe orthopnea with hypotension — Cardiogenic shock
- New orthopnea with syncope or near-syncope — Arrhythmia, critical valvular disease
- Orthopnea with stridor or inability to speak — Upper airway obstruction
- Rapid progression over hours — Flash pulmonary edema, acute valvular dysfunction
- Orthopnea with fever and rigors — Endocarditis, severe pneumonia
- New orthopnea post-myocardial infarction — Mechanical complications (ventricular septal defect, papillary muscle rupture)
Systematic History: The “PILLOW” Approach
Use the mnemonic “PILLOW” to ensure comprehensive history taking for orthopnea:
- P — Position and Pillows: How many pillows do you need? Can you lie flat at all? Do you sleep in a chair?
- I — Inception and Intensity: When did this start? Has it gotten worse? How quickly does breathlessness develop when lying flat?
- L — Linked symptoms: Do you have leg swelling, chest pain, palpitations, cough, or weight gain?
- L — Lying down effects: Do you wake up gasping at night? Is one side worse than the other? Does bending forward cause breathlessness?
- O — Other dyspnea patterns: Do you get breathless with exertion? Walking on flat ground or only on hills/stairs?
- W — What helps and what worsens: Does sitting up help? How long until you feel better? What makes it worse (salt, missed medications)?
Quantifying Orthopnea Severity
Essential Questions for Severity Assessment
- “How many pillows do you use to sleep?” — Document the number and compare to baseline
- “Can you lie flat for even a few minutes?” — Inability suggests severe disease
- “Do you ever sleep in a chair or recliner?” — Indicates severe orthopnea
- “How long after lying flat do you become breathless?” — Immediate (seconds) vs. delayed (minutes) onset
- “Has the number of pillows increased recently?” — Progressive worsening suggests decompensation
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Heart Failure | Leg swelling, weight gain, fatigue, reduced exercise tolerance | “Have you noticed your ankles swelling, especially by the end of the day?” “Have you gained weight recently without eating more?” |
| Paroxysmal Nocturnal Dyspnea | Sudden awakening 1-3 hours after sleep onset with severe dyspnea | “Do you ever wake up suddenly at night feeling like you can’t breathe? How long after falling asleep does this happen?” |
| Valvular Heart Disease | History of rheumatic fever, known murmur, atrial fibrillation | “Have you ever been told you have a heart murmur or valve problem?” “Did you have rheumatic fever as a child?” |
| Coronary Artery Disease | Chest pain, risk factors, known coronary disease | “Do you get chest pain or pressure when lying flat or with exertion?” “Have you had a heart attack or stents?” |
| Chronic Obstructive Pulmonary Disease | Smoking history, chronic cough, wheeze, sputum production | “Do you have a chronic cough or bring up phlegm?” “Do you wheeze when breathing?” |
| Obesity Hypoventilation Syndrome | Morbid obesity, daytime somnolence, snoring | “Do you snore loudly or stop breathing during sleep?” “Do you feel excessively sleepy during the day?” |
| Pleural Effusion | Pleuritic pain, reduced breath sounds, known malignancy or infection | “Do you have pain when taking a deep breath?” “Is your breathing worse lying on one particular side?” |
| Ascites | Abdominal distension, liver disease, malignancy | “Has your abdomen become more swollen or distended?” “Do you have liver problems or drink alcohol heavily?” |
| Diaphragmatic Weakness | Neuromuscular disease, prior thoracic surgery, trauma | “Do you have any muscle weakness elsewhere?” “Have you had surgery on your chest or neck?” |
| Pregnancy | Third trimester, multiple gestation | “Could you be pregnant?” “When is your due date?” |
Distinguishing Cardiac from Non-Cardiac Orthopnea
| Feature | Cardiac Orthopnea | Pulmonary/Mechanical Orthopnea |
|---|---|---|
| Onset after lying flat | Usually within 1-5 minutes | May be immediate or more gradual |
| Associated paroxysmal nocturnal dyspnea | Common (1-3 hours after sleep onset) | Less common |
| Peripheral edema | Usually present, worse at end of day | May be absent or due to other causes |
| Response to diuretics | Typically improves | May not improve significantly |
| Cough | Dry cough, worse at night | May be productive with sputum |
| Wheeze | “Cardiac asthma” — diffuse wheezes | May have localized or diffuse wheezes |
Medication and Compliance History
Medications That Can Worsen Orthopnea
- Non-steroidal anti-inflammatory drugs — Fluid retention, reduced renal function, antagonize diuretics
- Calcium channel blockers (non-dihydropyridine) — Negative inotropic effect, may worsen heart failure
- Thiazolidinediones (glitazones) — Fluid retention, contraindicated in heart failure
- Corticosteroids — Sodium and fluid retention
- Beta-blockers (if initiated too rapidly) — May precipitate acute decompensation
- Certain chemotherapy agents — Cardiotoxicity (anthracyclines, trastuzumab)
Critical Compliance Questions
- Diuretic compliance: “Have you been taking your water pill every day?”
- Dietary indiscretion: “Have you eaten any salty foods recently?” “Have you been to any restaurants or eaten processed foods?”
- Fluid restriction: “How much fluid do you drink each day?”
- Medication changes: “Have any of your medications been changed recently?”
- Daily weights: “Do you weigh yourself daily? Have you gained weight?”
Relevant Past Medical and Social History
Cardiac History
- Prior heart failure diagnosis and ejection fraction
- Previous myocardial infarction or coronary interventions
- Known valvular heart disease
- Atrial fibrillation or other arrhythmias
- Hypertension and control
- Congenital heart disease
- Prior cardiac surgeries
Pulmonary and Other History
- Chronic obstructive pulmonary disease or asthma
- Obstructive sleep apnea
- Pulmonary embolism history
- Interstitial lung disease
- Chronic kidney disease
- Liver cirrhosis
- Thyroid disease
- Diabetes mellitus
Social History Relevance
| Factor | Relevance to Orthopnea | Key Questions |
|---|---|---|
| Smoking | Risk factor for coronary disease, chronic obstructive pulmonary disease, lung cancer | “Do you smoke or have you ever smoked? How many pack-years?” |
| Alcohol | Alcoholic cardiomyopathy, liver cirrhosis with ascites | “How much alcohol do you drink? Have you ever been a heavy drinker?” |
| Illicit drugs | Cocaine cardiomyopathy, methamphetamine cardiomyopathy, endocarditis | “Have you ever used cocaine, methamphetamine, or injected drugs?” |
| Occupation | Asbestos exposure (pleural disease), dust exposure (interstitial lung disease) | “What type of work do you do? Any exposure to dust, chemicals, or asbestos?” |
| Diet | High sodium intake worsens fluid retention | “Do you add salt to your food? Do you eat a lot of processed or restaurant food?” |
Don’t Forget Family History
Important family history elements in patients with orthopnea include:
- Cardiomyopathy — Hypertrophic, dilated, or arrhythmogenic cardiomyopathy may be familial
- Premature coronary artery disease — First-degree relative with coronary disease before age 55 (males) or 65 (females)
- Sudden cardiac death — May indicate inherited arrhythmia syndrome or cardiomyopathy
- Heart failure at young age — Suggests possible genetic cardiomyopathy
4. Physical Examination
A systematic head-to-toe approach for Orthopnea
Systematic Framework: Use the “Cardiovascular-Pulmonary Integration” approach for complete examination of patients presenting with orthopnea. Remember that orthopnea is predominantly a cardiac symptom, so cardiovascular examination is paramount, but pulmonary and systemic findings provide crucial diagnostic information.
General Inspection
- Position of comfort: Is the patient sitting upright, leaning forward, or using accessory muscles? Inability to lie flat during examination is itself diagnostic
- Respiratory distress: Tachypnea, use of accessory muscles (sternocleidomastoid, scalenes), nasal flaring, pursed-lip breathing
- Color: Central cyanosis (lips, tongue), peripheral cyanosis (nail beds), pallor suggesting anemia
- Diaphoresis: Cool, clammy skin suggests poor cardiac output or acute pulmonary edema
- Cachexia: Cardiac cachexia indicates advanced, chronic heart failure
- Obesity: May contribute to orthopnea through mechanical effects and obesity hypoventilation
- Mental status: Confusion or somnolence may indicate hypoxemia, hypercapnia, or poor cerebral perfusion
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Heart Rate | Tachycardia (greater than 100 beats per minute), bradycardia, irregularity | Tachycardia compensates for reduced stroke volume; irregularly irregular suggests atrial fibrillation; bradycardia may indicate heart block or beta-blocker effect |
| Blood Pressure | Hypertension, hypotension, narrow pulse pressure, pulsus paradoxus | Hypotension with orthopnea suggests cardiogenic shock; narrow pulse pressure (less than 25% of systolic) indicates reduced stroke volume; pulsus paradoxus greater than 10 mmHg suggests tamponade |
| Respiratory Rate | Tachypnea (greater than 20 breaths per minute), Cheyne-Stokes pattern | Tachypnea indicates pulmonary congestion or hypoxemia; Cheyne-Stokes respiration (cyclic crescendo-decrescendo) suggests severe heart failure |
| Oxygen Saturation | Desaturation at rest, desaturation when supine | Desaturation when lying flat (compared to sitting) is objective evidence of orthopnea; correlates with severity of pulmonary congestion |
| Temperature | Fever, hypothermia | Fever suggests infection (endocarditis, pneumonia); hypothermia may indicate cardiogenic shock |
The Supine Test
A simple bedside test to objectively assess orthopnea:
- Measure oxygen saturation with patient sitting upright at 90 degrees
- Have patient lie flat (or as flat as tolerated)
- Measure oxygen saturation after 1-2 minutes in supine position
- A drop of greater than 4% suggests significant orthopnea and correlates with elevated filling pressures
Caution: Do not force patients with severe orthopnea to lie flat; severe respiratory distress can result.
Cardiovascular Examination
Jugular Venous Pressure
- Elevation: Jugular venous pressure greater than 8 cm H2O indicates elevated right atrial pressure
- Hepatojugular reflux: Sustained jugular venous pressure elevation greater than 3 cm with abdominal compression for 10-15 seconds indicates elevated right-sided filling pressures
- Waveform abnormalities: Giant V waves (tricuspid regurgitation), cannon A waves (complete heart block), absent A waves (atrial fibrillation)
Precordial Examination
| Finding | How to Assess | What It Indicates |
|---|---|---|
| Displaced apex beat | Apex lateral to midclavicular line or below 5th intercostal space | Left ventricular dilatation (dilated cardiomyopathy, chronic heart failure) |
| Diffuse apex beat | Apex impulse palpable over more than one intercostal space | Left ventricular dilatation |
| Sustained apex beat | Apex impulse continues through systole | Left ventricular hypertrophy (hypertensive heart disease, aortic stenosis) |
| Right ventricular heave | Parasternal lift palpable at left sternal border | Right ventricular hypertrophy or dilatation (pulmonary hypertension, right heart failure) |
| Palpable third heart sound | Low-frequency impulse after S2 | Severe left ventricular dysfunction with rapid early diastolic filling |
Cardiac Auscultation
| Finding | Description | Associated Conditions |
|---|---|---|
| Third heart sound (S3) | Low-pitched sound in early diastole, best heard at apex with bell; creates “Kentucky” gallop (S1-S2-S3) | Volume overload, reduced ejection fraction heart failure; most specific physical finding for elevated left ventricular filling pressure |
| Fourth heart sound (S4) | Low-pitched sound in late diastole (presystolic), best heard at apex with bell; creates “Tennessee” gallop (S4-S1-S2) | Reduced ventricular compliance, heart failure with preserved ejection fraction, hypertensive heart disease, acute myocardial infarction |
| Summation gallop | S3 and S4 merge at rapid heart rates creating single loud diastolic sound | Severe heart failure with tachycardia |
| Mitral regurgitation murmur | Pansystolic murmur at apex radiating to axilla | Primary mitral valve disease or functional regurgitation from left ventricular dilatation |
| Mitral stenosis murmur | Low-pitched diastolic rumble at apex with presystolic accentuation (if in sinus rhythm) | Rheumatic mitral stenosis; classic cause of orthopnea and pulmonary congestion |
| Aortic stenosis murmur | Harsh crescendo-decrescendo systolic murmur at right upper sternal border radiating to carotids | Severe aortic stenosis with heart failure |
| Tricuspid regurgitation murmur | Pansystolic murmur at left lower sternal border, increases with inspiration (Carvallo sign) | Right heart failure, pulmonary hypertension |
Pulmonary Examination
Inspection and Palpation
- Chest wall movement: Reduced expansion may indicate effusion, consolidation, or hyperinflation
- Barrel chest: Increased anteroposterior diameter suggests chronic obstructive pulmonary disease
- Tracheal position: Deviation away from large effusion; toward collapse or fibrosis
- Tactile fremitus: Decreased over effusion; increased over consolidation
Percussion
- Dullness at bases: Pleural effusion (stony dull) or consolidation
- Hyperresonance: Hyperinflation (chronic obstructive pulmonary disease, asthma) or pneumothorax
Auscultation
| Finding | Description | Associated Conditions |
|---|---|---|
| Bibasilar crackles (rales) | Fine, inspiratory crackles at lung bases that do not clear with coughing | Pulmonary edema from heart failure; classic finding correlating with orthopnea severity |
| Diffuse crackles | Crackles extending to mid or upper lung zones | Severe pulmonary edema; interstitial lung disease |
| Wheezes | Musical, high-pitched sounds during expiration | “Cardiac asthma” from bronchial edema in heart failure; chronic obstructive pulmonary disease; asthma |
| Decreased breath sounds | Reduced air entry, often at bases | Pleural effusion; consolidation; hyperinflation |
| Bronchial breathing | Harsh, tubular breath sounds with equal inspiratory and expiratory phases | Consolidation (pneumonia); large area of atelectasis |
Abdominal Examination
- Hepatomegaly: Tender, enlarged liver indicates hepatic congestion from right heart failure
- Hepatojugular reflux: Sustained jugular venous pressure rise with liver compression confirms elevated filling pressures
- Ascites: Shifting dullness and fluid wave indicate significant fluid accumulation; contributes to orthopnea by pushing diaphragm upward
- Pulsatile liver: Systolic hepatic pulsation indicates severe tricuspid regurgitation
Extremity Examination
- Peripheral edema: Bilateral pitting edema of ankles and legs; sacral edema in bedridden patients; indicates fluid overload
- Edema distribution: Symmetric bilateral suggests heart failure; unilateral may indicate deep vein thrombosis
- Skin changes: Chronic venous stasis changes (hemosiderin deposition, lipodermatosclerosis) indicate longstanding congestion
- Peripheral pulses: Weak or thready pulses suggest low cardiac output; assess for peripheral arterial disease
- Capillary refill: Prolonged (greater than 2 seconds) indicates poor peripheral perfusion
- Clubbing: May indicate chronic hypoxemia, endocarditis, or lung malignancy
- Temperature: Cool extremities suggest poor cardiac output and vasoconstriction
Expected Findings by Etiology
| Condition | Key Cardiovascular Findings | Key Pulmonary Findings | Other Findings |
|---|---|---|---|
| Heart Failure with Reduced Ejection Fraction | Displaced apex, S3 gallop, elevated jugular venous pressure, functional mitral regurgitation | Bibasilar crackles, possible pleural effusion | Peripheral edema, hepatomegaly, cool extremities |
| Heart Failure with Preserved Ejection Fraction | Sustained apex (left ventricular hypertrophy), S4 gallop, elevated jugular venous pressure, hypertension | Bibasilar crackles | Peripheral edema, often obese, atrial fibrillation common |
| Mitral Stenosis | Loud S1, opening snap, diastolic rumble at apex, right ventricular heave if pulmonary hypertension | Crackles, hemoptysis history | Mitral facies (malar flush), atrial fibrillation |
| Mitral Regurgitation | Displaced apex, pansystolic murmur at apex radiating to axilla, S3 | Pulmonary edema findings | Atrial fibrillation common |
| Chronic Obstructive Pulmonary Disease | Right ventricular heave if cor pulmonale, elevated jugular venous pressure, tricuspid regurgitation | Barrel chest, hyperresonance, decreased breath sounds, prolonged expiration, wheezes | Pursed-lip breathing, accessory muscle use, clubbing rare |
| Large Pleural Effusion | May have tracheal deviation away from effusion | Stony dullness to percussion, decreased breath sounds, decreased tactile fremitus | Trepopnea (worse lying on unaffected side) |
| Obesity Hypoventilation Syndrome | May have signs of right heart failure | Reduced chest wall excursion | Morbid obesity, somnolence, plethoric facies |
Important Teaching Point
The S3 gallop is the most specific physical finding for heart failure in patients with orthopnea. A third heart sound has a specificity of approximately 90-97% for elevated left ventricular filling pressure, though sensitivity is only 40-50%. When combined with elevated jugular venous pressure and peripheral edema in a patient with orthopnea, the diagnosis of decompensated heart failure is highly likely. However, remember that examination findings can be subtle, especially in early or well-compensated disease, and absence of classic findings does not exclude heart failure.
Clinical Signs Indicating Severity
Signs of Severe Decompensation Requiring Urgent Management
- Inability to lie flat for examination
- Resting tachypnea (greater than 25 breaths per minute)
- Hypotension (systolic blood pressure less than 90 mmHg)
- Oxygen saturation less than 90% on room air
- Cool, mottled extremities
- Altered mental status
- Diffuse pulmonary crackles (beyond bases)
- Anuria or oliguria
5. Differential Diagnosis
Systematic approach organized by probability and clinical features
Orthopnea is predominantly a symptom of cardiac disease, particularly left heart failure, but can also result from pulmonary, mechanical, and neuromuscular conditions. A systematic approach considering probability, acuity, and clinical context is essential for accurate diagnosis.
Clinical Approach to Orthopnea Differential:
- Step 1: Determine acuity — Is this acute (hours to days) or chronic (weeks to months)?
- Step 2: Assess for cardiac causes first — Heart failure is the most common cause by far
- Step 3: Evaluate for pulmonary causes — Especially if cardiac workup is unrevealing
- Step 4: Consider mechanical and neuromuscular causes — Particularly with atypical presentations
Acute Orthopnea (Onset: Hours to Days)
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (approximately 70%) | Acute Decompensated Heart Failure | Known heart failure, medication non-compliance, dietary indiscretion, recent infection; peripheral edema, elevated jugular venous pressure, S3 gallop | Hypotension, altered mental status, respiratory failure |
| COMMON | Acute Coronary Syndrome with Heart Failure | Chest pain, risk factors for coronary disease, new electrocardiogram changes, elevated troponin | ST elevation, hemodynamic instability, cardiogenic shock |
| LESS COMMON (approximately 20%) | Acute Valvular Dysfunction | Sudden onset, new murmur, may follow myocardial infarction (papillary muscle rupture) or endocarditis | Acute pulmonary edema, hemodynamic collapse |
| LESS COMMON | Hypertensive Emergency with Pulmonary Edema | Severely elevated blood pressure (usually greater than 180/120 mmHg), flash pulmonary edema, often preserved ejection fraction | End-organ damage (encephalopathy, acute kidney injury) |
| LESS COMMON | Acute Arrhythmia | Rapid atrial fibrillation, ventricular tachycardia, or heart block precipitating heart failure | Hemodynamic instability, syncope |
| UNCOMMON BUT SERIOUS (approximately 10%) | Cardiac Tamponade | Pulsus paradoxus, elevated jugular venous pressure, muffled heart sounds (Beck’s triad); may follow recent cardiac surgery or procedure | Hypotension, pulsus paradoxus greater than 10 mmHg |
| UNCOMMON BUT SERIOUS | Massive Pulmonary Embolism | Sudden dyspnea, pleuritic chest pain, risk factors for venous thromboembolism; right heart strain on echocardiography | Hypotension, syncope, hypoxemia |
| UNCOMMON BUT SERIOUS | Tension Pneumothorax | Sudden onset, unilateral decreased breath sounds, tracheal deviation; may follow trauma or procedure | Hemodynamic instability, tracheal deviation |
Chronic Orthopnea (Duration: Weeks to Months)
The “Big Four” Causes of Chronic Orthopnea
In ambulatory patients with chronic orthopnea, four conditions account for the vast majority of cases:
- Heart failure (most common — both reduced and preserved ejection fraction)
- Chronic valvular heart disease (especially mitral valve disease)
- Chronic obstructive pulmonary disease with or without cor pulmonale
- Obesity hypoventilation syndrome
| Probability | Condition | Approximate Frequency | Key Distinguishing Features |
|---|---|---|---|
| COMMON | Heart Failure with Reduced Ejection Fraction | 30-40% | Ejection fraction less than 40%; dilated left ventricle; S3 gallop; displaced apex; ischemic or non-ischemic etiology |
| COMMON | Heart Failure with Preserved Ejection Fraction | 25-35% | Ejection fraction greater than or equal to 50%; left ventricular hypertrophy; diastolic dysfunction on echocardiography; often elderly, female, hypertensive, obese |
| COMMON | Chronic Valvular Heart Disease | 10-15% | Characteristic murmurs; mitral stenosis and regurgitation most commonly cause orthopnea; aortic valve disease when severe |
| LESS COMMON | Chronic Obstructive Pulmonary Disease | 5-10% | Long smoking history; barrel chest; hyperinflation on imaging; prolonged expiratory phase; may have cor pulmonale with right heart failure |
| LESS COMMON | Obesity Hypoventilation Syndrome | 5-10% | Body mass index greater than 30 kg/m² (usually greater than 40); daytime hypercapnia; often coexists with obstructive sleep apnea; daytime somnolence |
| LESS COMMON | Large Pleural Effusion | 3-5% | Dullness to percussion; decreased breath sounds; may have trepopnea (worse lying on unaffected side); malignancy, heart failure, infection as causes |
| LESS COMMON | Severe Ascites | 2-5% | Abdominal distension; shifting dullness; often with liver cirrhosis, malignancy, or right heart failure |
| UNCOMMON | Bilateral Diaphragmatic Paralysis | Less than 2% | Severe orthopnea with marked supine desaturation; paradoxical abdominal movement; may follow cardiac surgery, trauma, or neuromuscular disease |
| UNCOMMON | Interstitial Lung Disease | Less than 2% | Dry cough; exertional dyspnea predominates; fine crackles; clubbing may be present; restrictive pattern on pulmonary function testing |
| UNCOMMON | Constrictive Pericarditis | Less than 1% | Elevated jugular venous pressure with prominent Y descent; Kussmaul sign; pericardial calcification on imaging; history of pericarditis, cardiac surgery, or radiation |
| UNCOMMON | Cardiac Tumor or Mass | Less than 1% | Atrial myxoma most common; may have positional symptoms; systemic symptoms (fever, weight loss); embolic events |
Anatomical Approach to Orthopnea
Cardiac Causes
Heart failure (reduced and preserved ejection fraction)
Valvular heart disease (mitral stenosis, mitral regurgitation, aortic stenosis)
Cardiomyopathy (dilated, hypertrophic, restrictive)
Constrictive pericarditis
Cardiac tamponade
Atrial myxoma
Acute coronary syndrome
Pulmonary Causes
Chronic obstructive pulmonary disease
Asthma (especially nocturnal)
Interstitial lung disease
Pulmonary embolism
Pleural effusion
Pneumonia
Pulmonary hypertension
Mechanical Causes
Obesity and obesity hypoventilation syndrome
Massive ascites
Pregnancy (third trimester)
Large abdominal mass
Severe kyphoscoliosis
Ankylosing spondylitis (chest wall restriction)
Neuromuscular Causes
Bilateral diaphragmatic paralysis
Amyotrophic lateral sclerosis
Myasthenia gravis
Muscular dystrophy
Guillain-Barré syndrome
Phrenic nerve injury (post-surgical)
Heart Failure Subtypes Causing Orthopnea
| Heart Failure Type | Ejection Fraction | Typical Patient Profile | Key Differentiating Features |
|---|---|---|---|
| Heart Failure with Reduced Ejection Fraction | Less than 40% | Prior myocardial infarction, dilated cardiomyopathy, younger males, coronary artery disease risk factors | Displaced and diffuse apex beat; S3 gallop; often ischemic etiology; responds to neurohormonal blockade |
| Heart Failure with Mildly Reduced Ejection Fraction | 41-49% | Intermediate phenotype; may progress to reduced or recover to preserved ejection fraction | Features of both reduced and preserved ejection fraction; benefits from guideline-directed therapy |
| Heart Failure with Preserved Ejection Fraction | 50% or greater | Elderly, female, hypertensive, obese, diabetic, atrial fibrillation common | Left ventricular hypertrophy; diastolic dysfunction; E/e’ ratio elevated; often normal-sized left ventricle |
| Right Heart Failure | Variable | Pulmonary hypertension, right ventricular infarction, chronic lung disease with cor pulmonale | Elevated jugular venous pressure; peripheral edema; hepatomegaly; tricuspid regurgitation; less prominent pulmonary congestion |
Drug-Induced and Iatrogenic Causes of Orthopnea
| Drug or Drug Class | Mechanism | Characteristics | Management |
|---|---|---|---|
| Non-steroidal anti-inflammatory drugs | Sodium and water retention; reduced renal prostaglandins; antagonize diuretics and angiotensin-converting enzyme inhibitors | Fluid overload; worsening of pre-existing heart failure; may precipitate acute decompensation | Discontinue; substitute acetaminophen or topical agents if analgesia needed |
| Thiazolidinediones (pioglitazone, rosiglitazone) | Increased sodium reabsorption in collecting duct; peripheral edema | Weight gain; peripheral edema; worsening heart failure; contraindicated in heart failure | Discontinue immediately; contraindicated in heart failure class III-IV |
| Non-dihydropyridine calcium channel blockers (verapamil, diltiazem) | Negative inotropic effect; may worsen systolic dysfunction | Worsening heart failure in patients with reduced ejection fraction | Avoid in heart failure with reduced ejection fraction; use with caution in preserved ejection fraction |
| Beta-blockers (if initiated or uptitrated rapidly) | Negative inotropic effect; may cause acute decompensation if started at high doses | Worsening symptoms in first 2-4 weeks of therapy; typically transient with slow uptitration | Start low, go slow; reduce dose if decompensation occurs; do not discontinue abruptly |
| Corticosteroids | Mineralocorticoid effect causing sodium and water retention | Fluid retention; hypertension; may precipitate heart failure in susceptible patients | Use lowest effective dose; monitor fluid status; consider diuretic adjustment |
| Anthracycline chemotherapy (doxorubicin, epirubicin) | Direct cardiotoxicity; dose-dependent cardiomyopathy | Dilated cardiomyopathy; may occur during treatment or years later; dose-dependent risk | Cardiac monitoring during treatment; serial echocardiography; limit cumulative dose |
| Trastuzumab (Herceptin) | HER2 receptor blockade in cardiac myocytes | Cardiomyopathy; often reversible with discontinuation; increased risk with anthracycline combination | Monitor ejection fraction; hold if significant decline; often reversible |
| Excessive intravenous fluids | Volume overload in patients with limited cardiac reserve | Acute pulmonary edema; often iatrogenic in hospital setting | Careful fluid management; avoid excessive crystalloid administration |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Orthopnea + bilateral leg edema + S3 gallop | Heart failure with reduced ejection fraction | Echocardiography; brain natriuretic peptide; electrocardiogram |
| Orthopnea + hypertension + left ventricular hypertrophy + elderly female | Heart failure with preserved ejection fraction | Echocardiography with diastolic assessment; brain natriuretic peptide |
| Orthopnea + diastolic murmur at apex + atrial fibrillation | Mitral stenosis | Echocardiography with mitral valve assessment |
| Orthopnea + pansystolic murmur at apex + dilated left ventricle | Mitral regurgitation (functional or primary) | Echocardiography; evaluate left ventricular function |
| Orthopnea + barrel chest + smoking history + prolonged expiration | Chronic obstructive pulmonary disease with or without cor pulmonale | Spirometry; chest radiograph; arterial blood gas |
| Orthopnea + morbid obesity + daytime somnolence + snoring | Obesity hypoventilation syndrome | Arterial blood gas (daytime hypercapnia); polysomnography |
| Orthopnea + unilateral dullness + decreased breath sounds | Large pleural effusion | Chest radiograph; thoracentesis |
| Orthopnea + abdominal distension + liver disease | Ascites with diaphragmatic elevation | Abdominal ultrasound; paracentesis if indicated |
| Severe orthopnea + marked supine desaturation + paradoxical abdominal movement | Bilateral diaphragmatic paralysis | Sniff test (fluoroscopy); pulmonary function with supine measurements; phrenic nerve studies |
| Orthopnea + elevated jugular venous pressure + Kussmaul sign + pericardial knock | Constrictive pericarditis | Computed tomography or magnetic resonance imaging for pericardial thickening; cardiac catheterization |
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
The diagnostic workup for orthopnea should be systematic and guided by clinical probability. Given that heart failure is the most common cause, initial investigations focus on cardiac assessment. The approach expands to pulmonary and other investigations when cardiac evaluation is unrevealing or when clinical features suggest alternative diagnoses.
Baseline Investigations for All Patients
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Electrocardiogram | Assess rhythm, ischemia, left ventricular hypertrophy, prior infarction | Atrial fibrillation; left ventricular hypertrophy; Q waves (prior myocardial infarction); ST-T changes; left bundle branch block | Normal electrocardiogram makes systolic heart failure less likely (negative predictive value approximately 90%) |
| Chest Radiograph | Assess heart size, pulmonary congestion, pleural effusions, lung parenchyma | Cardiomegaly (cardiothoracic ratio greater than 0.5); pulmonary venous congestion; Kerley B lines; pleural effusions; pulmonary infiltrates | May be normal in chronic compensated heart failure; acute changes may lag behind symptoms |
| Brain Natriuretic Peptide or N-terminal pro-brain natriuretic peptide | Biomarker for ventricular stretch and heart failure | Brain natriuretic peptide greater than 100 pg/mL or N-terminal pro-brain natriuretic peptide greater than 300 pg/mL suggests heart failure; higher levels indicate more severe disease | Excellent negative predictive value (greater than 95%); affected by age, renal function, obesity, atrial fibrillation |
| Complete Blood Count | Detect anemia (high-output failure), infection, polycythemia | Anemia (hemoglobin less than 12 g/dL in women, less than 13 g/dL in men); leukocytosis suggesting infection; polycythemia in chronic hypoxemia | Anemia can cause or exacerbate heart failure; correct if hemoglobin less than 10 g/dL |
| Basic Metabolic Panel | Assess renal function, electrolytes | Elevated creatinine (cardiorenal syndrome); hyponatremia (poor prognosis in heart failure); hypokalemia or hyperkalemia | Cardiorenal syndrome common; electrolyte abnormalities affect treatment options |
| Liver Function Tests | Assess hepatic congestion, congestive hepatopathy | Elevated transaminases (hepatic congestion); elevated bilirubin; low albumin (chronic congestion) | Right heart failure causes hepatic congestion; elevated liver enzymes indicate severity |
| Thyroid Function Tests | Detect thyroid disease as cause or exacerbating factor | Hyperthyroidism (high-output failure, atrial fibrillation); hypothyroidism (pericardial effusion, diastolic dysfunction) | Easily treatable cause of heart failure; should be checked in all new diagnoses |
| Troponin | Detect myocardial injury | Elevated in acute coronary syndrome; may be mildly elevated in acute heart failure without infarction | Mild elevation common in acute decompensation; marked elevation suggests acute coronary syndrome |
Interpreting Natriuretic Peptide Levels
Brain Natriuretic Peptide (pg/mL)
- Less than 100: Heart failure unlikely (negative predictive value greater than 95%)
- 100-400: Heart failure possible; consider clinical context
- Greater than 400: Heart failure likely
N-terminal pro-brain natriuretic peptide (pg/mL)
- Less than 300: Heart failure unlikely
- 300-900: Intermediate probability
- Greater than 900: Heart failure likely (age-adjusted cutoffs: greater than 450 if less than 50 years; greater than 900 if 50-75 years; greater than 1800 if greater than 75 years)
Caveats: Elevated in renal failure, atrial fibrillation, pulmonary embolism, pulmonary hypertension; reduced in obesity
Echocardiography: The Key Diagnostic Test
Echocardiography should be performed in all patients with orthopnea to assess:
- Left ventricular ejection fraction and systolic function
- Left ventricular size and wall thickness
- Diastolic function (E/A ratio, E/e’ ratio, deceleration time)
- Valvular structure and function
- Right ventricular size and function
- Estimated pulmonary artery systolic pressure
- Pericardial effusion or thickening
- Wall motion abnormalities suggesting ischemia
| Echocardiographic Finding | Measurement or Criteria | Clinical Significance |
|---|---|---|
| Left Ventricular Ejection Fraction | Normal: 55-70%; mildly reduced: 41-54%; reduced: less than 40% | Defines heart failure phenotype; guides treatment selection |
| E/e’ Ratio (diastolic function) | Normal: less than 8; elevated: greater than 14; indeterminate: 8-14 | E/e’ greater than 14 indicates elevated left atrial pressure |
| Left Atrial Volume Index | Normal: less than 34 mL/m²; dilated: greater than 34 mL/m² | Chronic marker of elevated filling pressures |
| Tricuspid Regurgitation Velocity | Pulmonary hypertension if greater than 2.8 m/s | Estimates pulmonary artery systolic pressure; elevated in left heart failure, pulmonary disease |
| Left Ventricular End-Diastolic Dimension | Normal: less than 56 mm (men), less than 52 mm (women) | Dilated in heart failure with reduced ejection fraction and volume overload |
| Interventricular Septal Thickness | Normal: 6-11 mm; hypertrophy: greater than 11 mm | Left ventricular hypertrophy indicates hypertensive heart disease, hypertrophic cardiomyopathy |
Targeted Investigations by Suspected Etiology
If Suspecting Coronary Artery Disease
First-Line Tests
- Electrocardiogram: Q waves, ST-T changes suggesting ischemia or prior infarction
- Troponin: Elevated if acute coronary syndrome
- Echocardiography: Regional wall motion abnormalities
Second-Line Tests
- Stress testing: Exercise or pharmacologic stress with imaging if intermediate probability
- Coronary computed tomography angiography: Non-invasive coronary assessment
- Invasive coronary angiography: Gold standard if high probability or for intervention
If Suspecting Heart Failure with Preserved Ejection Fraction
First-Line Tests
- Echocardiography: Preserved ejection fraction with diastolic dysfunction (E/e’ greater than 14)
- Natriuretic peptides: May be only modestly elevated (especially in obese patients)
Second-Line Tests
- Diastolic stress testing: Exercise echocardiography to unmask diastolic dysfunction
- Right heart catheterization: Gold standard; pulmonary capillary wedge pressure greater than 15 mmHg at rest or greater than 25 mmHg with exercise
If Suspecting Valvular Heart Disease
First-Line Tests
- Transthoracic echocardiography: Valve morphology, severity of stenosis or regurgitation, ventricular function
Second-Line Tests
- Transesophageal echocardiography: Better visualization of mitral valve, prosthetic valves, endocarditis
- Cardiac catheterization: Hemodynamic assessment; coronary evaluation pre-operatively
- Cardiac magnetic resonance imaging: Quantification of regurgitant volumes
If Suspecting Pulmonary Disease
First-Line Tests
- Spirometry: Obstructive pattern (forced expiratory volume in 1 second to forced vital capacity ratio less than 0.7) in chronic obstructive pulmonary disease; restrictive pattern in interstitial lung disease
- Chest radiograph: Hyperinflation, interstitial changes, pleural effusion
- Arterial blood gas: Hypoxemia; hypercapnia in obesity hypoventilation syndrome
Second-Line Tests
- Computed tomography of chest: Emphysema, interstitial lung disease, pulmonary embolism (computed tomography pulmonary angiography)
- Pulmonary function tests (full): Lung volumes, diffusion capacity
- Polysomnography: If obesity hypoventilation syndrome or obstructive sleep apnea suspected
If Suspecting Diaphragmatic Dysfunction
First-Line Tests
- Pulmonary function with supine testing: Greater than 25% decrease in forced vital capacity from sitting to supine highly suggestive of diaphragmatic weakness
- Chest radiograph: Elevated hemidiaphragm
Second-Line Tests
- Fluoroscopic sniff test: Paradoxical diaphragm movement on sniffing
- Phrenic nerve conduction studies: Confirm nerve dysfunction
- Diaphragm ultrasound: Assess diaphragm excursion and thickening
Empiric Treatment Trials as Diagnostic Tools
Therapeutic Trial Approach
In patients with orthopnea where the diagnosis is suspected but not confirmed, response to therapy can support the diagnosis:
- Diuretic trial: Improvement with diuresis strongly supports heart failure diagnosis. Give intravenous furosemide 40-80 mg (or double the patient’s oral dose) and assess response over 2-6 hours. Weight loss of 0.5-1 kg per day and symptomatic improvement support heart failure.
- Nitroglycerin trial: Improvement with sublingual nitroglycerin suggests elevated left ventricular filling pressures (heart failure or ischemia).
- Bronchodilator trial: If wheezing is present, improvement with bronchodilators may suggest airway disease component (but remember “cardiac asthma” may also improve due to reduced pulmonary congestion).
- Nocturnal oxygen trial: Improvement with nocturnal oxygen may suggest hypoxemia-related symptoms.
Stepwise Investigation Algorithm
Practical Approach to Investigating Orthopnea:
- Initial evaluation: Electrocardiogram, chest radiograph, brain natriuretic peptide, basic laboratory tests (complete blood count, metabolic panel, liver function, thyroid function, troponin)
- If brain natriuretic peptide elevated or clinical suspicion high: Transthoracic echocardiography
- If echocardiography shows reduced ejection fraction: Evaluate for ischemic etiology (stress testing or angiography); cardiac magnetic resonance imaging if cardiomyopathy etiology unclear
- If echocardiography shows preserved ejection fraction with diastolic dysfunction: Consider heart failure with preserved ejection fraction; evaluate for hypertensive heart disease, infiltrative cardiomyopathy
- If cardiac evaluation unrevealing: Spirometry, full pulmonary function tests, arterial blood gas, chest computed tomography
- If pulmonary evaluation unrevealing: Consider diaphragmatic dysfunction (sniff test, supine pulmonary function tests), neuromuscular disease, sleep-disordered breathing (polysomnography)
Special Considerations in Investigation
| Clinical Scenario | Additional Investigations to Consider | Rationale |
|---|---|---|
| Young patient with heart failure | Genetic testing for cardiomyopathy; cardiac magnetic resonance imaging; viral serologies; autoimmune workup | Higher likelihood of genetic or inflammatory cardiomyopathy |
| Suspected infiltrative cardiomyopathy | Cardiac magnetic resonance imaging with gadolinium; serum and urine protein electrophoresis; fat pad or endomyocardial biopsy | Amyloidosis, sarcoidosis, hemochromatosis require specific diagnosis and treatment |
| Suspected constrictive pericarditis | Computed tomography or magnetic resonance imaging for pericardial thickening; cardiac catheterization with hemodynamic assessment | Potentially curable with pericardiectomy if correctly diagnosed |
| Acute decompensation with normal brain natriuretic peptide | Consider flash pulmonary edema (hypertensive crisis); obesity (falsely low brain natriuretic peptide); constrictive pericarditis | Brain natriuretic peptide may be low in obesity and “flash” pulmonary edema |
| Discordance between symptoms and echocardiography | Right heart catheterization with exercise hemodynamics; diastolic stress testing | Unmask heart failure with preserved ejection fraction that is not apparent at rest |
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways
Clinical decision-making in orthopnea requires rapid triage to identify emergencies, systematic evaluation to determine etiology, and targeted management based on the underlying cause. This section provides practical algorithms and decision frameworks for the bedside clinician.
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Orthopnea with hypotension (systolic blood pressure less than 90 mmHg), altered mental status, or respiratory failure | EMERGENT | Activate rapid response or code team; obtain intravenous access; continuous monitoring; prepare for intubation; urgent echocardiography; inotropes or vasopressors as needed |
| Acute pulmonary edema with pink frothy sputum, severe dyspnea, oxygen saturation less than 90% | EMERGENT | Sit patient upright; high-flow oxygen or non-invasive positive pressure ventilation; intravenous furosemide 40-80 mg; intravenous nitroglycerin if blood pressure permits; urgent echocardiography |
| Orthopnea with chest pain concerning for acute coronary syndrome | EMERGENT | Electrocardiogram within 10 minutes; troponin; aspirin; consider urgent angiography if ST elevation or hemodynamic instability |
| New orthopnea with elevated jugular venous pressure and muffled heart sounds (concerning for tamponade) | EMERGENT | Urgent echocardiography; prepare for pericardiocentesis; intravenous fluids cautiously; avoid intubation if possible (can precipitate arrest) |
| Acute worsening of chronic orthopnea with stable vital signs and oxygen saturation greater than 92% | URGENT | Intravenous diuretics; supplemental oxygen; electrocardiogram; brain natriuretic peptide; chest radiograph; echocardiography within 24-48 hours |
| Chronic stable orthopnea with no acute change | ROUTINE | Optimize guideline-directed medical therapy; outpatient echocardiography if not recently performed; address medication compliance and dietary factors |
| Mild orthopnea in patient without known cardiac disease | ROUTINE | Outpatient workup with electrocardiogram, brain natriuretic peptide, echocardiography; evaluate for alternative causes |
Step 2: Classify by Severity and Acuity
Acute Severe Orthopnea
Features: Onset hours to days; unable to lie flat at all; respiratory distress at rest; oxygen saturation less than 92%
Action: Emergency management; consider intensive care unit admission; urgent echocardiography
Acute Moderate Orthopnea
Features: Recent worsening; requires 3+ pillows; stable vital signs; oxygen saturation greater than 92%
Action: Hospital admission; intravenous diuresis; telemetry monitoring; echocardiography within 24-48 hours
Chronic Stable Orthopnea
Features: Stable pillow requirement; no recent change; adequate oxygenation; known etiology
Action: Outpatient optimization; medication titration; dietary counseling; regular follow-up
Step 3: Follow the Appropriate Clinical Pathway
Pathway A: Acute Orthopnea with Suspected Heart Failure
| Clinical Scenario | Most Likely Diagnosis | Immediate Management |
|---|---|---|
| Elevated jugular venous pressure + S3 gallop + bilateral crackles + peripheral edema | Acute decompensated heart failure (wet and warm) | Intravenous furosemide (40-80 mg or 2.5× home dose); supplemental oxygen; fluid and sodium restriction; consider intravenous vasodilator if blood pressure permits |
| Elevated jugular venous pressure + bilateral crackles + cool extremities + hypotension | Cardiogenic shock (wet and cold) | Intensive care unit admission; inotropic support (dobutamine or milrinone); consider mechanical circulatory support; urgent cardiology consultation |
| Severe hypertension + acute pulmonary edema + preserved ejection fraction on prior echocardiography | Flash pulmonary edema (hypertensive emergency) | Intravenous nitroglycerin or nitroprusside; intravenous furosemide; blood pressure reduction by 20-25% in first hour |
| New atrial fibrillation with rapid ventricular response + orthopnea | Arrhythmia-induced heart failure | Rate control (intravenous diltiazem or metoprolol if no hypotension); consider cardioversion if unstable; anticoagulation |
| Recent myocardial infarction + new pansystolic murmur + acute pulmonary edema | Mechanical complication (ventricular septal defect or papillary muscle rupture) | Emergent echocardiography; intra-aortic balloon pump; emergent cardiac surgery consultation |
Pathway B: Chronic Orthopnea — Optimization Strategy
| Clinical Scenario | Optimization Strategy | Target Goals |
|---|---|---|
| Heart failure with reduced ejection fraction on suboptimal therapy | Uptitrate guideline-directed medical therapy: angiotensin-converting enzyme inhibitor/angiotensin receptor blocker/angiotensin receptor-neprilysin inhibitor, beta-blocker, mineralocorticoid receptor antagonist, sodium-glucose cotransporter-2 inhibitor | Maximum tolerated doses of all four pillars; consider device therapy (implantable cardioverter-defibrillator, cardiac resynchronization therapy) if eligible |
| Heart failure with preserved ejection fraction | Blood pressure control; diuretics for congestion; sodium-glucose cotransporter-2 inhibitor; treat comorbidities (atrial fibrillation, obesity, sleep apnea) | Euvolemia; blood pressure less than 130/80 mmHg; heart rate control if atrial fibrillation |
| Persistent orthopnea despite optimized therapy | Reassess volume status; consider ultrafiltration if diuretic resistant; evaluate for advanced heart failure therapies | Refer to advanced heart failure specialist if New York Heart Association class III-IV despite optimal therapy |
| Orthopnea from valvular heart disease | Evaluate for surgical or transcatheter intervention; optimize medical therapy while awaiting intervention | Surgical or transcatheter valve repair or replacement when indicated |
Pathway C: Non-Cardiac Orthopnea
| Suspected Cause | Confirmatory Testing | Management Approach |
|---|---|---|
| Chronic obstructive pulmonary disease with orthopnea | Spirometry showing obstruction; may have cor pulmonale on echocardiography | Optimize bronchodilators; consider nocturnal non-invasive ventilation if hypercapnic; treat right heart failure if present |
| Obesity hypoventilation syndrome | Daytime arterial blood gas showing hypercapnia (partial pressure of carbon dioxide greater than 45 mmHg); polysomnography | Weight loss; nocturnal positive airway pressure (bilevel preferred); treat comorbidities |
| Large pleural effusion | Chest radiograph and ultrasound; diagnostic thoracentesis | Therapeutic thoracentesis; treat underlying cause; consider indwelling pleural catheter if recurrent |
| Diaphragmatic paralysis | Supine pulmonary function tests showing greater than 25% drop in forced vital capacity; sniff test | Nocturnal non-invasive ventilation; consider diaphragm pacing in select cases; treat underlying cause if reversible |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Patient cannot lie flat for echocardiography | Perform echocardiography with patient sitting upright or in left lateral decubitus position | Adequate images usually obtainable; document patient position; consider transesophageal echocardiography if transthoracic inadequate |
| Brain natriuretic peptide is normal but clinical suspicion for heart failure is high | Consider false negative: obesity (reduces brain natriuretic peptide); flash pulmonary edema; constrictive pericarditis | Proceed with echocardiography; consider right heart catheterization if suspicion remains high |
| Diuretics are not producing adequate response | Increase dose (double if needed); switch to intravenous if giving oral; add thiazide for synergy (metolazone 2.5-5 mg before loop diuretic) | Consider continuous furosemide infusion; nephrology consultation; evaluate for ultrafiltration if refractory |
| Patient has both heart failure and chronic obstructive pulmonary disease | Treat both conditions; avoid non-selective beta-blockers; use cardioselective beta-blockers (bisoprolol, metoprolol succinate) | Optimize both cardiac and pulmonary therapies; ensure appropriate inhaler use; spirometry to confirm chronic obstructive pulmonary disease diagnosis |
| Patient refuses hospitalization despite significant orthopnea | Document informed refusal; optimize oral diuretics; provide clear return precautions; arrange close outpatient follow-up | Consider home health nursing; daily weights; same-week clinic follow-up; lower threshold for emergency department return |
| Orthopnea persists despite apparently adequate diuresis | Reassess volume status (jugular venous pressure, weight, urine output); consider other causes | Evaluate for mechanical causes (ascites, pleural effusion); consider obesity hypoventilation; pulmonary function tests |
| Patient has orthopnea with new murmur after recent myocardial infarction | Urgent echocardiography to evaluate for mechanical complication | If ventricular septal defect or severe mitral regurgitation, emergent surgical consultation; intra-aortic balloon pump for stabilization |
| Elderly patient with heart failure with preserved ejection fraction not improving with diuretics | Confirm diagnosis with natriuretic peptides and diastolic assessment; rule out other causes | Aggressive blood pressure control; consider sodium-glucose cotransporter-2 inhibitor; treat atrial fibrillation; address obesity and sleep apnea |
Disposition Decision Framework
| Disposition | Criteria | Management Requirements |
|---|---|---|
| Intensive Care Unit | Cardiogenic shock; need for inotropes or vasopressors; respiratory failure requiring intubation; acute mechanical complication | Continuous hemodynamic monitoring; intravenous vasoactive medications; mechanical ventilation or non-invasive ventilation; consider mechanical circulatory support |
| Cardiac Care Unit or Step-Down | Acute decompensated heart failure with marginal blood pressure; new arrhythmia; high-dose intravenous diuretics; active ischemia workup | Telemetry monitoring; intravenous diuretics; frequent reassessment; cardiology involvement |
| General Medical Ward | Stable acute decompensation; adequate blood pressure; no concerning arrhythmia; responding to diuretics | Daily weights; strict intake and output; transition to oral diuretics; optimization of heart failure therapy |
| Observation Unit | Mild decompensation; rapid response to initial diuresis; no high-risk features; reliable outpatient follow-up | 6-24 hour observation; intravenous diuretics; reassess for discharge versus admission |
| Discharge Home | Mild symptoms; responded to emergency department treatment; stable vital signs; reliable follow-up within 7 days; adequate social support | Adjust oral diuretics; reinforce dietary restrictions; daily weight monitoring; clear return precautions |
Troubleshooting Refractory Orthopnea
Ask These Questions When Orthopnea Persists Despite Treatment
- Is the diagnosis correct? Reassess for non-cardiac causes (obesity hypoventilation, diaphragm dysfunction, pulmonary disease)
- Is the patient truly euvolemic? Check jugular venous pressure, daily weights, consider ultrasound of inferior vena cava
- Is there diuretic resistance? Consider combination diuretic therapy (loop + thiazide), intravenous administration, or ultrafiltration
- Are all guideline-directed medical therapies optimized? Ensure maximum tolerated doses of neurohormonal blockers
- Are there comorbidities contributing? Obesity, sleep apnea, anemia, thyroid disease, uncontrolled atrial fibrillation
- Is there significant valvular disease requiring intervention? Repeat echocardiography if clinical change
- Is the patient a candidate for advanced therapies? Consider referral to advanced heart failure center for mechanical circulatory support or transplant evaluation
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
Orthopnea is predominantly cardiac: In patients with orthopnea, heart failure (reduced or preserved ejection fraction) accounts for approximately 80% of cases. Always prioritize cardiac evaluation with echocardiography and natriuretic peptides.
Quantify with pillows: Document the number of pillows at every visit. An increase in pillow requirement from 2 to 3 or needing to sleep in a chair indicates significant decompensation requiring intervention, even if the patient minimizes symptoms.
The S3 gallop is highly specific: A third heart sound has approximately 90-97% specificity for elevated left ventricular filling pressure. If you hear an S3 in a patient with orthopnea, heart failure is almost certainly the cause.
Brain natriuretic peptide has excellent negative predictive value: A brain natriuretic peptide less than 100 pg/mL (or N-terminal pro-brain natriuretic peptide less than 300 pg/mL) makes heart failure very unlikely (negative predictive value greater than 95%). Use this to rule out heart failure in uncertain cases.
Paroxysmal nocturnal dyspnea is more specific than orthopnea: While orthopnea has moderate specificity for heart failure (approximately 77%), paroxysmal nocturnal dyspnea is more specific. Ask specifically about sudden awakening with dyspnea 1-3 hours after falling asleep.
Consider the supine oxygen saturation test: A drop in oxygen saturation of greater than 4% when moving from sitting to supine provides objective evidence of orthopnea and correlates with elevated filling pressures. This is a simple, underutilized bedside assessment.
Heart failure with preserved ejection fraction is common and underrecognized: In elderly patients, especially women with hypertension, obesity, and diabetes, heart failure with preserved ejection fraction is the most common cause of orthopnea. Don’t dismiss heart failure just because ejection fraction is normal.
Nocturnal fluid redistribution explains paroxysmal nocturnal dyspnea: Peripheral edema accumulated during the day is mobilized over 1-3 hours of recumbency, causing delayed pulmonary congestion. This is why paroxysmal nocturnal dyspnea occurs hours after lying down, not immediately.
Critical Pitfalls to Avoid
Attributing orthopnea to “aging” or deconditioning: Orthopnea is always pathological and warrants investigation. Healthy elderly individuals do not develop orthopnea simply due to age. Never dismiss this symptom without appropriate workup.
Relying solely on chest radiograph to exclude pulmonary edema: Chest radiograph findings lag behind symptoms and physical examination. Up to 20% of patients with acutely elevated pulmonary capillary wedge pressure may have a relatively normal chest radiograph initially.
Missing heart failure with preserved ejection fraction: A normal ejection fraction does not exclude heart failure. Evaluate diastolic function (E/e’ ratio) and use natriuretic peptides. Many patients with orthopnea have heart failure with preserved ejection fraction.
Over-relying on brain natriuretic peptide in obese patients: Obesity causes falsely low brain natriuretic peptide levels. In obese patients with orthopnea, a “normal” brain natriuretic peptide of 80-100 pg/mL may actually represent heart failure. Maintain clinical suspicion.
Forgetting to ask about medication compliance and dietary indiscretion: Many acute heart failure admissions are triggered by non-compliance with diuretics, excessive sodium intake, or use of non-steroidal anti-inflammatory drugs. Always ask specifically about these factors.
Missing bilateral diaphragmatic paralysis: This cause of severe orthopnea is frequently overlooked because routine pulmonary function tests are performed sitting. Request supine pulmonary function tests if suspected — a greater than 25% drop in forced vital capacity is diagnostic.
Inadequate diuretic dosing: Patients with chronic heart failure often require higher diuretic doses than initially prescribed. If orthopnea persists, double the dose rather than accepting partial response. Don’t be afraid of appropriate diuresis.
Forgetting mechanical complications after myocardial infarction: New orthopnea with a murmur following myocardial infarction should prompt urgent echocardiography to evaluate for ventricular septal defect or papillary muscle rupture — these are surgical emergencies.
Key Takeaways
- Orthopnea is dyspnea occurring in the recumbent position, relieved by sitting upright. Quantify severity by the number of pillows required or need to sleep in a chair.
- Heart failure (both reduced and preserved ejection fraction) is the most common cause of orthopnea, accounting for approximately 80% of cases. Always prioritize cardiac evaluation.
- The pathophysiology involves fluid redistribution from lower extremities to central circulation when supine, overwhelming a compromised left ventricle and causing pulmonary congestion.
- Use the “PILLOW” mnemonic for systematic history: Position and Pillows, Inception and Intensity, Linked symptoms, Lying down effects, Other dyspnea patterns, What helps and worsens.
- Key examination findings include elevated jugular venous pressure, S3 gallop, bilateral pulmonary crackles, peripheral edema, and displaced apex beat.
- Brain natriuretic peptide and echocardiography are the cornerstone investigations. A low brain natriuretic peptide (less than 100 pg/mL) effectively excludes heart failure.
- Don’t forget non-cardiac causes: chronic obstructive pulmonary disease, obesity hypoventilation syndrome, large pleural effusion, ascites, and bilateral diaphragmatic paralysis.
- For acute decompensated heart failure, management includes intravenous diuretics, supplemental oxygen, fluid and sodium restriction, and optimization of guideline-directed medical therapy.
- Triage urgency based on vital signs: hypotension, respiratory failure, and altered mental status require emergent intervention.
- For refractory orthopnea, reassess the diagnosis, ensure adequate diuresis, optimize all medical therapies, and consider referral for advanced heart failure evaluation if appropriate.
Quick Reference Algorithm
Systematic Approach to Orthopnea:
- Triage: Assess vital signs, oxygen saturation, and severity. Identify emergencies (hypotension, respiratory failure, acute pulmonary edema) requiring immediate intervention.
- Quantify: Document pillow count, timing of onset, and presence of paroxysmal nocturnal dyspnea. Compare to baseline if known.
- Examine: Assess jugular venous pressure, cardiac auscultation (listen for S3), pulmonary auscultation (crackles), and peripheral edema. Perform supine oxygen saturation test if feasible.
- Investigate: Order electrocardiogram, chest radiograph, brain natriuretic peptide, basic metabolic panel, and troponin. Obtain echocardiography for all patients with suspected heart failure.
- Treat: For heart failure, initiate diuresis, oxygen, and fluid restriction. For acute decompensation, consider intravenous diuretics and vasodilators. Optimize guideline-directed medical therapy.
- Disposition: Base on severity and response to treatment. Intensive care unit for shock or respiratory failure; ward admission for moderate decompensation; discharge with close follow-up for mild symptoms with good response.
- Follow-up: Ensure medication optimization, dietary counseling, daily weight monitoring, and cardiology follow-up within 7 days of discharge for acute episodes.
High-Yield Summary Table
| Category | Key Points |
|---|---|
| Definition | Dyspnea in recumbent position, relieved by sitting upright; quantified by pillow count |
| Most Common Cause | Heart failure (reduced and preserved ejection fraction) — approximately 80% of cases |
| Pathophysiology | Fluid redistribution to central circulation when supine; overwhelms failing left ventricle; causes pulmonary congestion |
| History Mnemonic | PILLOW: Position/Pillows, Inception/Intensity, Linked symptoms, Lying down effects, Other dyspnea, What helps/worsens |
| Key Examination | Elevated jugular venous pressure, S3 gallop (highly specific), bilateral crackles, peripheral edema |
| Essential Investigations | Electrocardiogram, chest radiograph, brain natriuretic peptide (excellent negative predictive value), echocardiography |
| Treatment Priorities | Diuresis (intravenous for acute), oxygen, fluid restriction, guideline-directed medical therapy optimization |
| Don’t Forget | Heart failure with preserved ejection fraction in elderly; obesity hypoventilation syndrome; bilateral diaphragmatic paralysis; medication non-compliance |